INS and Alzheimer disease: Excitedly, preliminary studies have indicated that many antidiabetic drugs, such as liraglutide, pioglitazone, lixisenatide, rosiglitazone, insulin, and exendin-4, exhibited therapeutic effects on AD [9–14], suggesting that diabetes and AD may share genetic etiological risk factors, especially provide a potential novel approach for AD drug development.